I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 10 studies | 30% ± 12% | |
| type I pneumocyte | 9 studies | 22% ± 5% | |
| type II pneumocyte | 9 studies | 28% ± 6% | |
| endothelial cell | 9 studies | 31% ± 18% | |
| classical monocyte | 8 studies | 19% ± 3% | |
| naive B cell | 7 studies | 24% ± 7% | |
| fibroblast | 7 studies | 24% ± 11% | |
| GABAergic neuron | 7 studies | 39% ± 17% | |
| oligodendrocyte | 7 studies | 29% ± 8% | |
| monocyte | 6 studies | 18% ± 2% | |
| glutamatergic neuron | 6 studies | 47% ± 24% | |
| memory B cell | 6 studies | 23% ± 4% | |
| B cell | 6 studies | 21% ± 3% | |
| microglial cell | 6 studies | 23% ± 10% | |
| oligodendrocyte precursor cell | 6 studies | 33% ± 13% | |
| macrophage | 6 studies | 28% ± 10% | |
| regulatory T cell | 6 studies | 19% ± 2% | |
| T follicular helper cell | 5 studies | 20% ± 2% | |
| T cell | 5 studies | 18% ± 2% | |
| interneuron | 5 studies | 39% ± 22% | |
| natural killer cell | 5 studies | 21% ± 4% | |
| CD4-positive, alpha-beta memory T cell | 4 studies | 19% ± 3% | |
| myeloid cell | 4 studies | 25% ± 7% | |
| epithelial cell | 4 studies | 37% ± 9% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 16% ± 0% | |
| Mueller cell | 4 studies | 24% ± 9% | |
| retinal rod cell | 4 studies | 18% ± 2% | |
| CD8-positive, alpha-beta memory T cell | 4 studies | 17% ± 1% | |
| CD4-positive, alpha-beta T cell | 4 studies | 19% ± 4% | |
| hematopoietic precursor cell | 3 studies | 22% ± 5% | |
| precursor B cell | 3 studies | 19% ± 2% | |
| amacrine cell | 3 studies | 20% ± 4% | |
| retina horizontal cell | 3 studies | 20% ± 5% | |
| retinal cone cell | 3 studies | 18% ± 1% | |
| ciliated cell | 3 studies | 26% ± 4% | |
| pericyte | 3 studies | 23% ± 7% | |
| alveolar macrophage | 3 studies | 24% ± 8% | |
| gamma-delta T cell | 3 studies | 24% ± 10% | |
| neuron | 3 studies | 34% ± 9% | |
| immature B cell | 3 studies | 20% ± 5% | |
| plasmacytoid dendritic cell | 3 studies | 21% ± 6% | |
| CD8-positive, alpha-beta T cell | 3 studies | 18% ± 1% |
